0001193125-18-323752 Sample Contracts

Confidential Treatment Requested Centrexion Therapeutics Corporation AMENDMENT #1 TO PATENT ASSIGNMENT AND LICENSING AGREEMENT

Patent Assignment and Licensing Agreement • November 9th, 2018 • Centrexion Therapeutics Corp • Pharmaceutical preparations

• Contract Type
  Patent Assignment and Licensing Agreement
• Filed
  November 9th, 2018
• Company
  Centrexion Therapeutics Corp
• Industry
  Pharmaceutical preparations

This Amendment No. 1 (“Amendment No. 1”) to the Patent Assignment and Licensing Agreement by and between Boehringer Ingelheim International GmbH (“BII”) and Centrexion Therapeutics Corporation (“CENTREXION”), dated November 11, 2015, (the “Agreement”) is entered into effective as of January 29, 2018.